Nothing Special   »   [go: up one dir, main page]

BR9507438A - Composição oftálmica com viscosidade reduzida - Google Patents

Composição oftálmica com viscosidade reduzida

Info

Publication number
BR9507438A
BR9507438A BR9507438A BR9507438A BR9507438A BR 9507438 A BR9507438 A BR 9507438A BR 9507438 A BR9507438 A BR 9507438A BR 9507438 A BR9507438 A BR 9507438A BR 9507438 A BR9507438 A BR 9507438A
Authority
BR
Brazil
Prior art keywords
amount
pct
weight
viscosity
composition
Prior art date
Application number
BR9507438A
Other languages
English (en)
Inventor
Timo Reunamaki
Kari Lehmussaari
Eija Vartiainen
Olli Oksala
Sakari Alaranta
Esko Pohjala
Original Assignee
Timo Reunamaki
Kari Lehmussaari
Eija Vartiainen
Olli Oksala
Sakari Alaranta
Esko Pohjala
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Timo Reunamaki, Kari Lehmussaari, Eija Vartiainen, Olli Oksala, Sakari Alaranta, Esko Pohjala filed Critical Timo Reunamaki
Publication of BR9507438A publication Critical patent/BR9507438A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BR9507438A 1994-03-31 1995-03-29 Composição oftálmica com viscosidade reduzida BR9507438A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9401108A SE9401108D0 (sv) 1994-03-31 1994-03-31 Ophthalmic composition I
PCT/FI1995/000166 WO1995026711A1 (en) 1994-03-31 1995-03-29 Ophthalmic composition with decreased viscosity

Publications (1)

Publication Number Publication Date
BR9507438A true BR9507438A (pt) 1997-09-16

Family

ID=20393511

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9507438A BR9507438A (pt) 1994-03-31 1995-03-29 Composição oftálmica com viscosidade reduzida

Country Status (27)

Country Link
US (1) US5710182A (pt)
EP (1) EP0752847B1 (pt)
JP (1) JPH10503470A (pt)
KR (1) KR100365914B1 (pt)
CN (1) CN1112918C (pt)
AT (1) ATE202921T1 (pt)
AU (1) AU694497B2 (pt)
BG (1) BG63145B1 (pt)
BR (1) BR9507438A (pt)
CA (1) CA2186734A1 (pt)
CZ (1) CZ290987B6 (pt)
DE (2) DE69521686T2 (pt)
DK (1) DK0752847T3 (pt)
EE (1) EE03661B1 (pt)
ES (1) ES2161874T3 (pt)
GR (1) GR3036763T3 (pt)
HK (1) HK1013953A1 (pt)
HU (1) HU223071B1 (pt)
MX (1) MX9603918A (pt)
NO (1) NO314434B1 (pt)
PL (1) PL179433B1 (pt)
PT (1) PT752847E (pt)
RO (1) RO115409B1 (pt)
RU (1) RU2139016C1 (pt)
SE (1) SE9401108D0 (pt)
SK (1) SK280492B6 (pt)
WO (1) WO1995026711A1 (pt)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9718568D0 (en) 1997-09-03 1997-11-05 Chauvin Pharmaceuticals Limite Compositions
AU4808000A (en) 1999-04-28 2000-11-10 Situs Corporation Drug delivery system
US6852688B2 (en) 2000-03-10 2005-02-08 University Of Florida Compositions for treating diabetic retinopathy and methods of using same
CN1638734A (zh) * 2002-02-22 2005-07-13 参天制药株式会社 微粒结膜下给药的药物释放系统
US7128928B2 (en) * 2002-02-22 2006-10-31 Pharmacia Corporation Ophthalmic formulation with novel gum composition
JP2004196787A (ja) * 2002-12-04 2004-07-15 Santen Pharmaceut Co Ltd 結膜下デポによるドラッグデリバリーシステム
EP1568359A4 (en) * 2002-12-04 2011-05-18 Santen Pharmaceutical Co Ltd DRUG DELIVERY SYSTEM HAVING SUB-CONJUNCTIVAL DEPOSIT
US7947295B2 (en) * 2003-06-13 2011-05-24 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
CA2839847C (en) * 2003-06-13 2016-03-15 Masood A. Chowhan Ophthalmic compositions containing a synergistic combination of two polymers
WO2005018608A1 (ja) * 2003-08-20 2005-03-03 Santen Pharmaceutical Co., Ltd. 微粒子テノン嚢下投与ドラッグデリバリーシステム
TWI367098B (en) * 2004-12-23 2012-07-01 Kowa Co Treating agent for glaucoma
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
DE102005035986B4 (de) * 2005-07-28 2009-10-15 Bausch & Lomb Incorporated Steriles tropfbares mehrphasiges emulgatorfreies ophthalmisches Präparat
EP2334686B1 (en) 2008-08-28 2019-02-27 President and Fellows of Harvard College Cortistatin analogues and syntheses therof
EP2383286A1 (en) 2010-04-30 2011-11-02 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and compositions for treatment of retinal degenerative diseases
JP2012180346A (ja) * 2011-02-10 2012-09-20 Santen Pharmaceut Co Ltd 親水性薬物の薬物移行性を改善した水性組成物
WO2013124477A1 (en) 2012-02-24 2013-08-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and compositions for treatment of retinal degenerative diseases
SG10201808151RA (en) 2013-12-24 2018-10-30 Harvard College Cortistatin analogues and syntheses and uses thereof
EP3294298A4 (en) 2015-05-08 2018-10-17 President and Fellows of Harvard College Cortistatin analogues, syntheses, and uses thereof
WO2017004411A1 (en) 2015-07-01 2017-01-05 President And Fellows Of Harvard College Cortistatin analogues and syntheses and uses thereof
EP3340982B1 (en) 2015-08-26 2021-12-15 Achillion Pharmaceuticals, Inc. Compounds for treatment of immune and inflammatory disorders
AR106018A1 (es) 2015-08-26 2017-12-06 Achillion Pharmaceuticals Inc Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos
CN109475756A (zh) 2016-02-17 2019-03-15 儿童医疗中心有限公司 Ffa1(gpr40)作为神经血管生成疾病或病症的治疗标靶
MX2018016046A (es) 2016-06-27 2019-05-02 Achillion Pharmaceuticals Inc Quinazolina y compuestos indol para tratar trastornos medicos.
WO2018033854A1 (en) * 2016-08-15 2018-02-22 Santen Pharmaceutical Co., Ltd. Ophthalmic composition and a method for treating ocular hypertension and glaucoma
US9867810B1 (en) 2016-08-19 2018-01-16 Orasis Pharmaceuticals Ltd. Ophthalmic pharmaceutical compositions and uses relating thereto
KR102632860B1 (ko) 2017-03-01 2024-02-02 아칠리온 파르마세우티칼스 인코포레이티드 의학적 장애의 치료를 위한 아릴, 헤테로아릴, 및 헤테로사이클릭 약학적 화합물
PT3548000T (pt) * 2017-05-11 2021-12-10 Vyluma Inc Composiões farmacológicas com atropina
EP3773576A4 (en) 2018-03-26 2021-12-29 C4 Therapeutics, Inc. Cereblon binders for the degradation of ikaros
WO2020041301A1 (en) 2018-08-20 2020-02-27 Achillion Pharmaceuticals, Inc. Pharmaceutical compounds for the treatment of complement factor d medical disorders
CN113365617A (zh) 2018-10-16 2021-09-07 乔治亚州立大学研究基金会股份有限公司 用于医学疾病治疗的一氧化碳前药
CA3165309A1 (en) 2020-03-05 2021-09-10 Christopher G. Nasveschuk Compounds for targeted degradation of brd9
EP4288049A1 (en) * 2021-02-04 2023-12-13 Sydnexis, Inc. Ophthalmic compositions for presbyopia
EP4088713A1 (en) 2021-05-10 2022-11-16 Warszawskie Zaklady Farmaceutyczne Polfa S.A. Ophthalmic pharmaceutical composition comprising atropine
EP4088714A1 (en) 2021-05-10 2022-11-16 Warszawskie Zaklady Farmaceutyczne Polfa S.A. Ophthalmic pharmaceutical composition comprising atropine
CN113786380A (zh) * 2021-09-18 2021-12-14 华北制药股份有限公司 一种硝酸毛果芸香碱眼用凝胶及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6056684B2 (ja) * 1977-11-07 1985-12-11 東興薬品工業株式会社 点眼剤
US5252318A (en) * 1990-06-15 1993-10-12 Allergan, Inc. Reversible gelation compositions and methods of use
FR2678832B1 (fr) * 1991-07-10 1995-03-17 Europhta Sa Laboratoire Nouvelles compositions ophtalmiques a resorption amelioree et leurs procedes de preparation.

Also Published As

Publication number Publication date
SE9401108D0 (sv) 1994-03-31
DE69521686D1 (de) 2001-08-16
BG100915A (en) 1997-07-31
AU2138995A (en) 1995-10-23
ES2161874T3 (es) 2001-12-16
CN1112918C (zh) 2003-07-02
HK1013953A1 (en) 1999-09-17
PT752847E (pt) 2001-12-28
JPH10503470A (ja) 1998-03-31
DE69521686T2 (de) 2002-04-25
NO964070L (no) 1996-11-28
RO115409B1 (ro) 2000-02-28
HU223071B1 (hu) 2004-03-01
PL316584A1 (en) 1997-01-20
NO314434B1 (no) 2003-03-24
NO964070D0 (no) 1996-09-27
HU9602691D0 (en) 1996-11-28
SK280492B6 (sk) 2000-03-13
DE752847T1 (de) 1997-09-04
RU2139016C1 (ru) 1999-10-10
AU694497B2 (en) 1998-07-23
US5710182A (en) 1998-01-20
EP0752847A1 (en) 1997-01-15
EE9600120A (et) 1997-04-15
CN1144477A (zh) 1997-03-05
DK0752847T3 (da) 2001-10-22
ATE202921T1 (de) 2001-07-15
PL179433B1 (pl) 2000-09-29
EP0752847B1 (en) 2001-07-11
WO1995026711A1 (en) 1995-10-12
BG63145B1 (bg) 2001-05-31
GR3036763T3 (en) 2001-12-31
CA2186734A1 (en) 1995-10-12
KR100365914B1 (ko) 2003-04-16
KR970702024A (ko) 1997-05-13
EE03661B1 (et) 2002-04-15
CZ290987B6 (cs) 2002-11-13
CZ286596A3 (en) 1997-04-16
MX9603918A (es) 1997-04-30
SK123996A3 (en) 1997-06-04
HUT75666A (en) 1997-05-28

Similar Documents

Publication Publication Date Title
BR9507438A (pt) Composição oftálmica com viscosidade reduzida
SE9401109D0 (sv) Opthalmic composition II
US5945121A (en) Liposome eye drops
KR960700081A (ko) 콘택트렌즈 용액 보존 시스템(preservative system for contact lens solutions)
NZ230663A (en) Antimicrobial, hypotonic, aqueous contact lens composition
CA2183547A1 (en) Compositions for treating defective cell functions
NO940160D0 (no) Oeyepreparater inneholdende oxicam eller oxicamderivater
KR940006575A (ko) 증가된 안내압 치료를 위한 안구 국소 투여용 약제학적 조성물
WO2009006130A3 (en) Salt free hyaluronate ophthalmic solution
JPS6452727A (en) Antiallergic eye drop
FI963744A (fi) Alennetun viskositeetin omaava oftalminen koostumus
AU2001242398A1 (en) Contact lens treating method and composition
JPS6217973B2 (pt)

Legal Events

Date Code Title Description
PC Transfer

Free format text: SANTEN OY (FI)

HJEG Technical examination (opinion): technical examination (opinion) related to article 229 of industrial property law
FF Decision: intention to grant
B24C Patent annual fee: request for for restoration

Free format text: REFERENTE 12A., 13A., 14A., 15A. E 16A. ANUIDADE(S).

B24H Lapse because of non-payment of annual fees (definitively: art 78 iv lpi)
B24F Patent annual fee: publication cancelled

Free format text: ANULADA A PUBLICACAO CODIGO 24.8 NA RPI NO 2257 DE 08/04/2014 POR TER SIDO INDEVIDA.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE AS 12A, 13A, 14A, 15A E 16A ANUIDADES.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2606 DE 15-12-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.